Latest Content From Ruairi MacKenzie
Starkey Hearing Technologies recently unveiled their latest hearing aid, the Livio AI. Starkey says the device does a lot more than just assist in hearing, and includes a range of additional technology, such as a physical activity tracker and integrated language translation.
Cell-Free Technology is taking a unique approach to protein technology with their BioBits initiative, which they say combines the ease of use of a digital design tool with the detailed scientific validation provided by a CRO. We catch up with Cell-Free CEO Tom Meany to discuss the new technology.VIEW
A new 4D computational model which integrates CRISPR, confocal microscopy, and machine learning allows researchers to study the dynamics of specific proteins which drive mitosis. The model is a framework which can be adapted to study other cellular functions.VIEW
Electronic Lab Notebooks (ELNs) are often advertised as the next step in laboratory technology, but uptake has remained stubbornly low despite a wide range of solutions being available on the market. Here, we ask ELN provider labfolder's Co-Founder and CEO Simon Bungers what the industry can do to improve uptake, and how ELNs can answer the question of how to improve data integrity in modern research.VIEW
Many recent advances in research have aimed to maximize the amount of data we can produce. But handling all that data is a challenge, and in analytical chemistry, data has more complexity and value than everyday spreadsheets, and tools matching that complexity will be needed to get data back into shape. We discussed how the field should approach these challenges with Andrew Anderson and , Graham McGibbon of Toronto-based analytical software supplier ACD/Labs.VIEW
Genedata’s Screener software aims to streamline data workflows and make analysis easier. We caught up with Dr. Oliver Leven, Head of Genedata Screener Business Europe, to discuss how we researchers can make data more standardized, accessible and shareable whilst not compromising on security and integrity.VIEW
Personalized medicine isn’t all about our DNA. Researchers are increasingly looking past the information encoded on our genes to find answers to how individual variation contributes to complex disease. Companies like the Cambridge-based Microbiotica are much more interested in the bacterial cells that live inside us; our microbiome.VIEW
A research group has announced that DNA sequenced from an ancient bone fragment found in a cave in Russia suggests it came from a hybrid of two now-extinct groups of archaic humans, Neanderthals and Denisovans. The findings shed light on how these two species interacted and implies that Denisovan/Neanderthal mating was far more common than first thought.
No scientist is an island, and to maximize the power of data, researchers have to share their results with the wider community. Now, GenScript's launch of its MolecularCloud platform suggests sharing plasmid data may become easier than ever before.VIEW